Advancing Digital Therapeutics with Medidata and Click Therapeutics
Medidata and Click Therapeutics are joining forces to transform the future of digital therapeutics (DTx) — not just in clinical trials, but across the entire patient journey, from study participation to ongoing care.
Together, this partnership creates an end-to-end offering that unifies clinical research and DTx technologies to support Prescription Digital Therapeutics (PDTs) and Software-Enhanced (SE) drugs, setting a new gold standard in patient-centric care.
Where Clinical Trial Activities Meet Digital Therapeutics
With FDA guidance on Prescription Drug Use-Related Software (PDURS), now is the time to expand and enhance treatment options for patients with Digital Therapeutics.
Medidata and Click Therapeutics extend patient engagement beyond the trial, creating lifelong connections from clinical trials to continuous care using DTx.
Interested in learning more? Sign-up to be notified as more information becomes available.